SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Non-Current Liabilities | ₹176 Cr | ₹123 Cr | ₹138 Cr |
What is the latest Total Non-Current Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹176 Cr |
| Mar2024 | ₹123 Cr |
| Mar2023 | ₹138 Cr |
How is Total Non-Current Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹176 Cr | 43.07 | |
| Mar2024 | ₹123 Cr | -11.15 | |
| Mar2023 | ₹138 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,309.4 Cr | -3.8% | 0.9% | -36.1% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹26,009.7 Cr | 2.5% | -0.9% | -24.1% | Stock Analytics | |
| SAGILITY INDIA | ₹23,593.9 Cr | 4.2% | -0.9% | 24.4% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹10,046.2 Cr | 2.2% | 1.3% | -3.8% | Stock Analytics | |
| JUST DIAL | ₹6,030.5 Cr | 0.2% | -8% | -32.4% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹3,689.2 Cr | 4.2% | -7.3% | -31.2% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -3.8% |
0.9% |
-36.1% |
| SENSEX | 0% |
0.1% |
3.9% |
You may also like the below Video Courses